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Problem Definition
• Percutaneous coronary intervention (PCI) is one of 
the most common procedures performed in 
hospitals around the country each year.
• In-stent thrombosis is the most significant 
potential complication of this procedure, often 
occurring in the first month and with a high rate of 
mortality and morbidity.
• Patient compliance with dual antiplatelet therapy 
(DAPT) after hospital discharge is the most 
effective strategy in preventing in-stent thrombosis 
and hospital readmission from PCI-related 
complications.
• Transition of care from hospital to discharge is a 
common source of systems-based error.
• Inefficiencies in patient health education, 
coordination of transportation, family support in 
discharge process, and variability in pharmacy 
accessibility may all contribute to medication non-
adherence.
• Delivery of discharge medications from an 
inpatient pharmacy prior to hospital departure may 
avoid these potential pitfalls.
• To reduce the rate of this institution’s 
readmission rate in patients discharged after 
PCI, by identifying the current trends in 
readmission in relation to prescription and 
medication delivery practices over the past 1 
year. 
• The National Cardiovascular Data Registry 
(NCDR) database was queried for all patients who 
received PCI at TJUH from Sept 2017-Sept 2018.
• Through extensive chart review, information on 
discharge medication list, pharmacy used, and 
rates of readmission at 30-, 60-, and 90-day 
intervals was collected.
• Planned hospital readmissions for staged PCI-
procedures were identified but not included as the 
population of interest
• A total of 210 PCI procedures were performed 
at TJUH during the study period. 
• In these patients, discharge medication 
prescriptions were delivered to:
TJUH pharmacy - 59 patients
Outside pharmacy - 151 patients
• Total hospital readmission rate was 17%
• Conclusions: Patients who received 
discharge medications from outside 
pharmacies had higher rates of hospital 
readmission than those who received their 
medications from the inpatient pharmacy.
• The majority of patients have discharge 
prescriptions sent to their home pharmacies. 
• An in-house discharge prescription program 
may be of benefit institutionally.
• Limitations: Hospital readmission to 
another institution was not included in our 
analysis and may underestimate the rate of 
PCI-related complications in our cohort.
• Medication issues that were addressed by 
physician phone call or urgent clinic visit were 
not included in this analysis, which may 
underestimate the rates of medication 
confusion and non-adherence.
• Future directions: Elucidating reasons 
behind the pattern or patient preference of 
using outside pharmacies (i.e. business hours, 
home delivery, pharmacist teaching).
• Development of an in-house discharge 
prescription program.
• An analysis of more recent data, over a longer 
period of time, or after a discharge 
prescription protocol has been put in place.
• Expansion of the outcome variables studied 
may better identify at risk patients and areas 
for improvement.
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Readmission  # of patients TJUH Pharmacy 
Outside 
Pharmacy
0-30 days 19 4 (7%) 15 (10%) 
31-60 days 7 1 (2%) 6 (4%)
61-90 days 9 2 (3%) 7 (5%) 
Total 35 (17%) 7 (12%) 28 (19%)
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